Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

23 Sep 2014 07:00

RNS Number : 2851S
Standard Life Euro Pri Eqty Tst PLC
23 September 2014
 



Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2014

 

· NAV rose by 3.4% to 260.9p for the quarter ended 30 June 2014

· NAV total return was up 9.1% for the nine months from 1 October 2013

· Realised gains and income during the quarter ended 30 June 2014 were £5.3 million (1.3% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were £21.8 million (5.4% of NAV); in addition, there were unrealised foreign exchange losses of £11.2 million (2.8% of NAV)

· 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2014

· Outstanding commitments were £191.1 million at 30 June 2014

· Cash balance was £18.1 million and £22.0 million was invested in equity index tracker funds at 30 June 2014

 

For the quarter ended 30 June 2014 the Company's net asset value per ordinary share ("NAV") rose by 3.4% to 260.9p, from 252.2p at 31 March 2014. At 30 June 2014 the Company's net assets were £415.1 million (31 March 2014 - £401.2 million).

 

The volume of new buy-out transactions rose modestly in the European private equity market in the second quarter of 2014, while the enterprise value of buy-outs announced increased to €21.1 billion, from €14.0 billion in the first quarter of 2014. The second quarter also witnessed increasing mergers and acquisitions activity in Europe and a continuing flow of exits from private equity controlled investments.

 

The closing value of the Company's portfolio of 42 private equity fund interests was £374.5 million at 30 June 2014 (31 March 2014 - £356.4 million). The total unrealised gains on the portfolio for the quarter ended 30 June 2014 were £10.6 million, of which £21.8 million were unrealised gains on a constant exchange rate basis and £11.2 million were unrealised foreign exchange losses. The £21.8 million of gains in the value of the portfolio on a constant exchange rate basis reflected positive earnings growth at many underlying portfolio companies and a small rise in listed equity markets. The MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) rose by 2.6% and 1.3% respectively during the quarter. The unrealised foreign exchange losses were driven by the euro and, to a lesser extent, the US dollar depreciating by 3.2% and 2.6% respectively relative to sterling over the quarter.

 

During the quarter ended 30 June 2014 the Company funded £15.3 million of draw downs (six months ended 31 March 2014 - £15.9 million) and received £13.0 million of distributions (six months ended 31 March 2014 - £49.3 million). Draw down activity increased during the quarter as a result of new investment activity by a number of recent fund commitments, notably Permira V where draw downs totalled £5.2 million. While it was a quieter quarter for distributions, the Manager was aware of a number of exits where the Company was awaiting cash proceeds. The Company has received significant distributions subsequent to the period end. The distributions received during the quarter generated £5.3 million of realised gains and income, which was equivalent to a return of 1.7 times the acquisition cost of the realised investments. Total draw downs and distributions for the nine months ended 30 June 2014 were £31.2 million and £62.3 million, respectively.

 

The Company made no new fund commitments in the quarter ended 30 June 2014. The Company had total outstanding commitments to its 42 private equity fund interests of £191.1 million at 30 June 2014 (31 March 2014 - £213.5 million). The Manager now believes that up to £45 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2014 the Company had a cash balance, including holdings in money market funds,

of £18.1 million and had £22.0 million (£21.1 million at cost) invested in UK and European equity index tracker funds (31 March 2014 - £22.7 million and £21.9 million, respectively). The Company continues to have an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

 

2. Activity since 30 June 2014

 

During the period from 1 July to 22 September 2014 the Company funded £13.3 million of draw downs and received £33.6 million of distributions. The Company also made a new commitment of €55.0 million to Altor IV, a Nordic mid-market buy-out fund, in July 2014.

 

At 22 September 2014 the Company had a cash balance, including holdings in money market funds, of £28.7 million and had £31.2 million (£30.1 million at cost) invested in UK and European equity index tracker funds. The Company also had total outstanding commitments of £219.5 million.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2014 on or around 8 December 2014.

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZLLFLZKFFBBB
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.